Roivant Sciences (ROIV) Revenue (2020 - 2025)

Roivant Sciences' Revenue history runs 6 years deep, the most recent figure standing at $5.7 million for Q4 2025.

• Quarterly Revenue fell 73.28% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31.0 million (down 46.28% YoY) and the FY2026 annual result came in at $8.3 million, down 71.57% from the prior year.
• Revenue was $5.7 million for Q4 2025 at Roivant Sciences, up from $1.6 million in the prior quarter.
• Across five years, Revenue topped out at $46.1 million in Q4 2021 and bottomed at $1.6 million in Q3 2025.
• A 5-year average of $14.1 million and a median of $8.0 million in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2021 — Revenue surged 957.22% — and 2025, when it sank 73.28%.
• Roivant Sciences' Revenue stood at $46.1 million in 2021, then retreated by 26.4% to $33.9 million in 2022, then tumbled by 30.12% to $23.7 million in 2023, then declined by 9.33% to $21.5 million in 2024, then sank by 73.28% to $5.7 million in 2025.
• Business Quant data shows ROIV's Revenue at $5.7 million in Q4 2025, $1.6 million in Q3 2025, and $2.2 million in Q2 2025.